Loading…

LBO-06-Interim safety and efficacy results of the ABI-H0731 phase 2a program exploring the combination of ABI-H0731 with Nuc therapy in treatment-naive and treatment-suppressed chronic hepatitis B patients

Saved in:
Bibliographic Details
Published in:Journal of hepatology 2019-04, Vol.70 (1), p.e130-e130
Main Authors: Ma, Xiaoli, Lalezari, Jacob, Nguyen, Tuan, Bae, Ho, Schiff, Eugene R., Fung, Scott, Yuen, Man-Fung, Hassanein, Tarek, Hann, Hie-Won, Elkhashab, Magdy, Dieterich, Douglas, Sulkowski, Mark, Kwo, Paul, Nahass, Ronald, Agarwal, Kosh, Ramji, Alnoor, Park, James, Ravendhran, Natarajan, Chan, Sing, Weilert, Frank, Han, Steven-Huy, Ayoub, Walid, Gane, Edward, Jacobson, Ira, Bennett, Michael, Huang, Qi, Yan, Ran, Huey, Vivian, Ruby, Eric, Liaw, Sandy, Colonno, Richard, Lopatin, Uri
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0168-8278
1600-0641
DOI:10.1016/S0618-8278(19)30230-0